feed,title,long_url,short_url
Yahoo,Gilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity,https://finance.yahoo.com/news/gilead-analysts-downplay-q2-miss-165639501.html,https://j.mp/33bDQTK
